EXCLUSIVE- CHINA IS IN TALKS WITH PFIZER INC FOR LICENCE TO MANUFACTURE AND DISTRIBUTE A GENERIC VERSION OF THE U.S. FIRM'S COVID-19 ANTIVIRAL DRUG PAXLOVID IN CHINA -SOURCES